Source 1primary paper2026MED
Toolkit/multi-antigen CAR designs
multi-antigen CAR designs
Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Key developments include multi-antigen and logic-gated CAR designs to mitigate tumor immune evasion.
Usefulness & Problems
Why this is useful
Multi-antigen CAR designs are described as next-generation engineering strategies in GBM CAR-T therapy. The abstract states they are used to mitigate tumor immune evasion.; broadening antigen coverage in glioblastoma CAR-T therapy
Source:
Multi-antigen CAR designs are described as next-generation engineering strategies in GBM CAR-T therapy. The abstract states they are used to mitigate tumor immune evasion.
Source:
broadening antigen coverage in glioblastoma CAR-T therapy
Problem solved
They are presented as a response to glioblastoma barriers including intratumoral heterogeneity and antigenic escape.; mitigates tumor immune evasion
Source:
They are presented as a response to glioblastoma barriers including intratumoral heterogeneity and antigenic escape.
Source:
mitigates tumor immune evasion
Problem links
mitigates tumor immune evasion
LiteratureThey are presented as a response to glioblastoma barriers including intratumoral heterogeneity and antigenic escape.
Source:
They are presented as a response to glioblastoma barriers including intratumoral heterogeneity and antigenic escape.
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Architecture: A reusable architecture pattern for arranging parts into an engineered system.
Mechanisms
Translation ControlTechniques
Computational DesignTarget processes
translationImplementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: regulator
Operational role: regulator. Implementation mode: genetically encoded. Cofactor status: cofactor requirement unknown.
Independent follow-up evidence is still limited. Validation breadth across biological contexts is still narrow. Independent reuse still looks limited, so the evidence base may be fragile. No canonical validation observations are stored yet, so context-specific performance remains under-specified.
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
In glioblastoma, intratumoral heterogeneity, antigenic escape, an immunosuppressive tumor microenvironment, and blood-brain barrier constraints limit CAR-T cell trafficking, persistence, and sustained antitumor activity in the central nervous system.
Successful translation of CAR-T cell therapy to solid tumors remains a major unmet clinical challenge.
Armored CAR-T cells can be engineered for cytokine delivery or resistance to suppressive mediators such as TGF-β in glioblastoma.
Multi-antigen and logic-gated CAR designs are being developed to mitigate tumor immune evasion in glioblastoma.
Approval Evidence
1 source3 linked approval claimsfirst-pass slug multi-antigen-car-designs
Key developments include multi-antigen and logic-gated CAR designs to mitigate tumor immune evasion.
Source:
barrier statementsupports
In glioblastoma, intratumoral heterogeneity, antigenic escape, an immunosuppressive tumor microenvironment, and blood-brain barrier constraints limit CAR-T cell trafficking, persistence, and sustained antitumor activity in the central nervous system.
Source:
challenge statementsupports
Successful translation of CAR-T cell therapy to solid tumors remains a major unmet clinical challenge.
Source:
engineering strategysupports
Multi-antigen and logic-gated CAR designs are being developed to mitigate tumor immune evasion in glioblastoma.
Source:
Comparisons
Source-stated alternatives
The abstract also mentions logic-gated CAR designs, armored CAR-T cells, checkpoint-resistant constructs, and combinatorial immunotherapy strategies.
Source:
The abstract also mentions logic-gated CAR designs, armored CAR-T cells, checkpoint-resistant constructs, and combinatorial immunotherapy strategies.
Source-backed strengths
explicitly positioned as a key next-generation CAR engineering development
Source:
explicitly positioned as a key next-generation CAR engineering development
Compared with armored CAR-T cells
The abstract also mentions logic-gated CAR designs, armored CAR-T cells, checkpoint-resistant constructs, and combinatorial immunotherapy strategies.
Shared frame: source-stated alternative in extracted literature
Strengths here: explicitly positioned as a key next-generation CAR engineering development.
Source:
The abstract also mentions logic-gated CAR designs, armored CAR-T cells, checkpoint-resistant constructs, and combinatorial immunotherapy strategies.
Compared with CAR-T
The abstract also mentions logic-gated CAR designs, armored CAR-T cells, checkpoint-resistant constructs, and combinatorial immunotherapy strategies.
Shared frame: source-stated alternative in extracted literature
Strengths here: explicitly positioned as a key next-generation CAR engineering development.
Source:
The abstract also mentions logic-gated CAR designs, armored CAR-T cells, checkpoint-resistant constructs, and combinatorial immunotherapy strategies.
Compared with CAR-T cells
The abstract also mentions logic-gated CAR designs, armored CAR-T cells, checkpoint-resistant constructs, and combinatorial immunotherapy strategies.
Shared frame: source-stated alternative in extracted literature
Strengths here: explicitly positioned as a key next-generation CAR engineering development.
Source:
The abstract also mentions logic-gated CAR designs, armored CAR-T cells, checkpoint-resistant constructs, and combinatorial immunotherapy strategies.
Compared with CAR-T cell therapy
The abstract also mentions logic-gated CAR designs, armored CAR-T cells, checkpoint-resistant constructs, and combinatorial immunotherapy strategies.
Shared frame: source-stated alternative in extracted literature
Strengths here: explicitly positioned as a key next-generation CAR engineering development.
Source:
The abstract also mentions logic-gated CAR designs, armored CAR-T cells, checkpoint-resistant constructs, and combinatorial immunotherapy strategies.
Compared with CAR-T therapy
The abstract also mentions logic-gated CAR designs, armored CAR-T cells, checkpoint-resistant constructs, and combinatorial immunotherapy strategies.
Shared frame: source-stated alternative in extracted literature
Strengths here: explicitly positioned as a key next-generation CAR engineering development.
Source:
The abstract also mentions logic-gated CAR designs, armored CAR-T cells, checkpoint-resistant constructs, and combinatorial immunotherapy strategies.
Compared with Chimeric Antigen Receptor (CAR) T-cell therapy
The abstract also mentions logic-gated CAR designs, armored CAR-T cells, checkpoint-resistant constructs, and combinatorial immunotherapy strategies.
Shared frame: source-stated alternative in extracted literature
Strengths here: explicitly positioned as a key next-generation CAR engineering development.
Source:
The abstract also mentions logic-gated CAR designs, armored CAR-T cells, checkpoint-resistant constructs, and combinatorial immunotherapy strategies.
Compared with chimeric antigen receptor T cells
The abstract also mentions logic-gated CAR designs, armored CAR-T cells, checkpoint-resistant constructs, and combinatorial immunotherapy strategies.
Shared frame: source-stated alternative in extracted literature
Strengths here: explicitly positioned as a key next-generation CAR engineering development.
Source:
The abstract also mentions logic-gated CAR designs, armored CAR-T cells, checkpoint-resistant constructs, and combinatorial immunotherapy strategies.
Compared with Chimeric antigen receptor T-cell therapy
The abstract also mentions logic-gated CAR designs, armored CAR-T cells, checkpoint-resistant constructs, and combinatorial immunotherapy strategies.
Shared frame: source-stated alternative in extracted literature
Strengths here: explicitly positioned as a key next-generation CAR engineering development.
Source:
The abstract also mentions logic-gated CAR designs, armored CAR-T cells, checkpoint-resistant constructs, and combinatorial immunotherapy strategies.
Compared with logic-gated CAR designs
The abstract also mentions logic-gated CAR designs, armored CAR-T cells, checkpoint-resistant constructs, and combinatorial immunotherapy strategies.
Shared frame: source-stated alternative in extracted literature
Strengths here: explicitly positioned as a key next-generation CAR engineering development.
Source:
The abstract also mentions logic-gated CAR designs, armored CAR-T cells, checkpoint-resistant constructs, and combinatorial immunotherapy strategies.
Ranked Citations
- 1.